WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+9.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$11.8B
AUM Growth
+$1.41B
(+13%)
Cap. Flow
+$896M
Cap. Flow
% of AUM
7.57%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
744
New
202
Increased
220
Reduced
152
Closed
160
Top Buys
| 1 |
ASML
ASML
|
+$125M |
| 2 |
Meta Platforms (Facebook)
META
|
+$100M |
| 3 |
STMicroelectronics
STM
|
+$92.5M |
| 4 |
MetLife
MET
|
+$79.4M |
| 5 |
Gilead Sciences
GILD
|
+$77.3M |
Top Sells
| 1 |
TE Connectivity
TEL
|
+$161M |
| 2 |
Eli Lilly
LLY
|
+$151M |
| 3 |
Marsh & McLennan
MMC
|
+$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$86.7M |
| 5 |
Electronic Arts
EA
|
+$78.6M |
Sector Composition
| 1 | Healthcare | 43.57% |
| 2 | Technology | 17.47% |
| 3 | Industrials | 8.1% |
| 4 | Energy | 6.42% |
| 5 | Financials | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
476
Tectonic Therapeutic, Inc. Common Stock
TECX
$319M
| $1.98M | 0.02% |
+65,448
| New | +$1.98M |
|
477
Relay Therapeutics
RLAY
$703M
| $1.96M | 0.02% |
276,904
+3,288
| +1% | +$23.3K |
|
478
Lexicon Pharmaceuticals
LXRX
$407M
| $1.9M | 0.02% |
+1,211,924
| New | +$1.9M |
|
|
SLRN
479
DELISTED
ACELYRIN
SLRN
| $1.76M | 0.01% |
357,094
-1,627,716
| -82% | -$8.02M |
|
480
MP Materials
MP
$11.2B
| $1.76M | 0.01% |
+99,512
| New | +$1.76M |
|
481
Trane Technologies
TT
$90.9B
| $1.72M | 0.01% |
+4,423
| New | +$1.72M |
|
|
TWFG
482
TWFG, Inc. Common Stock
TWFG
$378M
| $1.68M | 0.01% |
+62,000
| New | +$1.68M |
|
|
THRD
483
DELISTED
Third Harmonic Bio
THRD
| $1.68M | 0.01% |
+123,923
| New | +$1.68M |
|
484
ImmunityBio
IBRX
$2.38B
| $1.64M | 0.01% |
439,818
+1,975
| +0.5% | +$7.35K |
|
485
The Beauty Health Co
SKIN
$309M
| $1.57M | 0.01% |
1,091,000
-1,411,320
| -56% | -$2.03M |
|
486
Protara Therapeutics
TARA
$120M
| $1.56M | 0.01% |
851,567
+751,566
| +752% | +$1.38M |
|
487
Zscaler
ZS
$43.8B
| $1.54M | 0.01% |
9,030
-17,153
| -66% | -$2.93M |
|
|
RGLS
488
DELISTED
Regulus Therapeutics
RGLS
| $1.49M | 0.01% |
948,702
+1,017
| +0.1% | +$1.6K |
|
489
DigitalOcean
DOCN
$3.13B
| $1.49M | 0.01% |
36,865
-55,419
| -60% | -$2.24M |
|
490
SPS Commerce
SPSC
$4.18B
| $1.45M | 0.01% |
+7,475
| New | +$1.45M |
|
491
Alto Neuroscience
ANRO
$102M
| $1.43M | 0.01% |
125,000
| – | – |
|
492
Brinker International
EAT
$6.98B
| $1.41M | 0.01% |
18,435
-73,760
| -80% | -$5.64M |
|
|
PSTX
493
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.37M | 0.01% |
+478,861
| New | +$1.37M |
|
494
Tyra Biosciences
TYRA
$633M
| $1.31M | 0.01% |
55,866
-32,790
| -37% | -$771K |
|
495
AST SpaceMobile
ASTS
$10B
| $1.31M | 0.01% |
+50,000
| New | +$1.31M |
|
496
Pliant Therapeutics
PLRX
$107M
| $1.25M | 0.01% |
111,660
+8,037
| +8% | +$90.1K |
|
497
Masimo
MASI
$8.03B
| $1.24M | 0.01% |
9,300
-176,690
| -95% | -$23.6M |
|
498
HUB Group
HUBG
$2.25B
| $1.23M | 0.01% |
+27,001
| New | +$1.23M |
|
499
Stoke Therapeutics
STOK
$1.18B
| $1.16M | 0.01% |
94,382
-5,800
| -6% | -$71.3K |
|
500
Hanover Insurance
THG
$6.41B
| $1.15M | 0.01% |
+7,750
| New | +$1.15M |
|